Literature DB >> 15214809

Homology modeling of lanosterol 14alpha-demethylase of Candida albicans and Aspergillus fumigatus and insights into the enzyme-substrate Interactions.

C Sheng1, W Zhang, M Zhang, Y Song, H Ji, J Zhu, J Yao, J Yu, S Yang, Y Zhou, J Zhu, J Lu.   

Abstract

The crystal structure of 14alpha-sterol demethylase from Mycobacterium tuberculosis (MT_14DM) provides a good template for modeling the three dimensional structure of lanosterol 14alpha-demethylase, which is the target of azole antifungal agents. Homologous 3D models of lanosterol 14alpha-demethylase from Candida albicans (CA_14DM) and Aspergillus fumigatus (AF_14DM) were built on the basis of the crystal coordinates of MT_14DM in complex with 4-phenylimidazole and fluconazole. The reliability of the two models was assessed by Ramachandran plots, Profile-3D analysis, and by analyzing the consistency of the two models with the experimental data on the P450(14DM). The overall structures of the resulting CA_14DM model and AF_14DM model are similar to those of the template structures. The two models remain the core structure characteristic for cytochrome P450s and most of the insertions and deletions expose the molecular surface. The structurally and functionally important residues such as the heme binding residues, the residues lining the substrate access channel, and residues in active site were identified from the model. To explore the binding mode of the substrate with the two models, 24(28)-methylene-24,25-dihydrolanosterol was docked into the active site of the two models and hydrophobic interaction and hydrogen-bonding were found to play an important role in substrate recognition and orientation. These results provided a basis for experiments to probe structure-function relationships in the P450(14DM). Although CA_14DM and AF_14DM shared similar core structural character, the active site of the two models were quite different, thus allowing the rational design of specific inhibitors to the target enzyme and the discovery of novel antifungal agents with broad spectrum. Copyright 2004 Adenine Press

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15214809     DOI: 10.1080/07391102.2004.10506984

Source DB:  PubMed          Journal:  J Biomol Struct Dyn        ISSN: 0739-1102


  7 in total

1.  Three-dimensional model of lanosterol 14 alpha-demethylase from Cryptococcus neoformans: active-site characterization and insights into azole binding.

Authors:  Chunquan Sheng; Zhenyuan Miao; Haitao Ji; Jianzhong Yao; Wenya Wang; Xiaoying Che; Guoqiang Dong; Jiaguo Lü; Wei Guo; Wannian Zhang
Journal:  Antimicrob Agents Chemother       Date:  2009-05-26       Impact factor: 5.191

2.  X-ray structure of 4,4'-dihydroxybenzophenone mimicking sterol substrate in the active site of sterol 14alpha-demethylase (CYP51).

Authors:  Ali Nasser Eddine; Jens P von Kries; Mikhail V Podust; Thulasi Warrier; Stefan H E Kaufmann; Larissa M Podust
Journal:  J Biol Chem       Date:  2008-03-26       Impact factor: 5.157

3.  Evolutionary trace analysis of CYP51 family: implication for site-directed mutagenesis and novel antifungal drug design.

Authors:  Chunquan Sheng; Shuanghong Chen; Haitao Ji; Guoqiang Dong; Xiaoyin Che; Wenya Wang; Zhenyuan Miao; Jianzhong Yao; Jiaguo Lü; Wei Guo; Wannian Zhang
Journal:  J Mol Model       Date:  2009-07-11       Impact factor: 1.810

4.  The protein farnesyltransferase inhibitor Tipifarnib as a new lead for the development of drugs against Chagas disease.

Authors:  Oliver Hucke; Michael H Gelb; Christophe L M J Verlinde; Frederick S Buckner
Journal:  J Med Chem       Date:  2005-08-25       Impact factor: 7.446

5.  Amino acid substitutions at the major insertion loop of Candida albicans sterol 14alpha-demethylase are involved in fluconazole resistance.

Authors:  Nidia Alvarez-Rueda; Audrey Fleury; Florent Morio; Fabrice Pagniez; Louis Gastinel; Patrice Le Pape
Journal:  PLoS One       Date:  2011-06-16       Impact factor: 3.240

6.  Pharmacophore-Based Virtual Screening of Novel Inhibitors and Docking Analysis for CYP51A from Penicillium italicum.

Authors:  Yongze Yuan; Rui Han; Qianwen Cao; Jinhui Yu; Jiali Mao; Tingfu Zhang; Shengqiang Wang; Yuhui Niu; Deli Liu
Journal:  Mar Drugs       Date:  2017-04-05       Impact factor: 5.118

7.  Identification of 1, 2, 4-Triazine and Its Derivatives Against Lanosterol 14-Demethylase (CYP51) Property of Candida albicans: Influence on the Development of New Antifungal Therapeutic Strategies.

Authors:  Abhishek Kumar Verma; Aarfah Majid; Md Shahadat Hossain; Sk Faisal Ahmed; Mohammad Ashid; Ali Asger Bhojiya; Sudhir K Upadhyay; Naveen Kumar Vishvakarma; Mudassir Alam
Journal:  Front Med Technol       Date:  2022-03-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.